Skip to main content

Richman Darren's Form 4 filing

Rapid Micro Biosystems, Inc.RPID · filed May 26, 2022

Accession no.
0000899243-22-019820
Filed
May 26, 2022, 8:00 PM ET
Trade date
May 25-26, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market purchases total $228.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Richman DarrenCIK 000159447410% Owner
Chene DavidCIK 000179723710% Owner
Kennedy Lewis Management LPCIK 000179763310% Owner
Kennedy Lewis Investment Management LLCCIK 000179763410% Owner
KLM GP LLCCIK 000179776710% Owner
Kennedy Lewis Investment Holdings II LLCCIK 000185497710% Owner
Kennedy Lewis Capital Partners Master Fund II LPCIK 000185502310% Owner
Kennedy Lewis GP II LLCCIK 000185502410% Owner
Kennedy Lewis Capital Partners Master Fund III LPCIK 000189689810% Owner
Kennedy Lewis GP III LLCCIK 000189720910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 25, 2022Common StockPPurchaseAcquired+11,867$4.36F1+$51,716.391,973,717Indirect
May 25, 2022Common StockPPurchaseAcquired+16,933$4.36F1+$73,794.012,816,414Indirect
May 26, 2022Common StockPPurchaseAcquired+8,687$4.90F8+$42,589.751,982,404Indirect
May 26, 2022Common StockPPurchaseAcquired+12,396$4.90F8+$60,773.872,828,810Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares of Common Stock of Rapid Micro Biosystems, Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $4.2 to $4.43, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in footnotes (1) and (8) to this Form 4.

Referenced by the price of 2 transactions in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares of Common Stock of the Issuer were sold in multiple transactions at prices ranging from $4.5 to $5, inclusive.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)